光子计数CT在放疗中的定性专家访谈评估
本研究通过半结构化专家访谈评估光子计数CT(PCCT)在放疗中的潜在临床价值。针对八个治疗部位,专家团队对十项应用陈述进行5分Likert评分,共收集80个评分。结果显示光谱数据应用评分最高,骨、头颈和肺部肿瘤评分最高,前列腺未发现额外价值。
要点
- 光谱数据应用和分辨率提升被评为PCCT最具临床价值的优势。
- 骨、头颈和肺部肿瘤是PCCT临床价值评分最高的治疗部位。
- 前列腺肿瘤未发现PCCT的额外临床价值。
核心结论
- PCCT在放疗中最具附加临床价值的优势为光谱数据的使用和分辨率的提高。
- 头颈、骨和肺部肿瘤评分最高,可作为首批临床实施领域。
研究设计与样本
- 对八个治疗部位开展半结构化专家团队访谈,每个团队由2名放射肿瘤科医生和1名放射科医生组成。
- 访谈中展示PCCT图像特征后,专家对十项陈述进行5分Likert评分(0=无附加临床价值,4=临床不可或缺)。
主要发现
- 共收集80个评分,涵盖十项陈述和八个治疗部位。
- 关于光谱数据使用的陈述附加临床价值评分最高,而降低成像剂量评分最低。
- 骨、头颈和肺部肿瘤评分最高,前列腺评分最低且未发现附加价值。
关键数值与推荐
- 评分采用5分Likert量表:0=无附加临床价值,4=临床不可或缺。
- 共收集80个评分(十项陈述×八个治疗部位)。
临床怎么用
- 头颈、骨和肺部肿瘤可优先考虑PCCT的临床实施。
- 光谱数据应用和分辨率提升是PCCT在放疗中应重点关注的特性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Photon-counting CT (PCCT) has several potential benefits that can considerably improve the radiotherapy workflow, like availability of intrinsic spectral data and high resolution imaging. It is unknown which treatment sites in radiotherapy will benefit the most from PCCT. This study aimed to identify clinical applications and treatment sites where PCCT may have the most clinical value. MATERIALS AND METHODS: Semi-structured interviews with expert teams were conducted about eight treatment sites. Each expert team consisted of 2 radiation oncologists and 1 radiologist with expertise in specific treatment site. During each session, PCCT images were shown to demonstrate specific PCCT features: instantly changing the energy from 40 to 190 keV with a slider, iodine maps, contrast-agent removal and high-resolution images. Next, the experts scored ten statements about clinical applications for added clinical value on a 5-point Likert scale, from 0=No added clinical value to 4 = Indispensable for the clinic. RESULTS: A total of 80 scores were collected about ten statements and eight treatment sites. The statements about the use of spectral data scored highest for added clinical value, while reducing imaging dose scored lowest. The radiotherapy treatment sites with the highest scores were bone, head and neck and lung tumors, while lowest was prostate where no added value was found. CONCLUSION: Semi-structured interviews identified advantages of PCCT that may have the most added clinical value for radiotherapy: the use of spectral data and increased resolution. Head and neck, bone and lung tumors are the clinical applications which were scored highest in terms of added clinical value and these could therefore be the first areas for clinical implementation.
引用
- Kroes-Kobus T, Rossi L, Nuyttens JJME, et al. Photon-counting CT for radiotherapy: Qualitative assessment of potential clinical value by semi-structured expert interviews. Clin Transl Radiat Oncol. 2026. PMID: 41798869. doi:10.1016/j.ctro.2026.101135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。